Symbols / ENVB $1.96 -3.30% Enveric Biosciences, Inc.

Healthcare • Biotechnology • United States • NCM
ENVB Chart
About

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 3.71M
Enterprise Value -972.26K Income -12.13M Sales —
Book/sh 3.94 Cash/sh 2.48 Dividend Yield —
Payout 0.00% Employees 5 IPO —
P/E 0.00 Forward P/E -1.39 PEG —
P/S — P/B 0.50 P/C —
EV/EBITDA 0.11 EV/Sales — Quick Ratio 5.09
Current Ratio 5.38 Debt/Eq — LT Debt/Eq —
EPS (ttm) -36.24 EPS next Y -1.41 EPS Growth —
Revenue Growth — Earnings 2025-03-28 17:00 ROA -134.11%
ROE -3.04% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 1.89M
Shs Float 1.85M Short Float 6.77% Short Ratio 0.09
Short Interest — 52W High 17.84 52W Low 1.75
Beta 0.33 Avg Volume 360.71K Volume 19.96K
Target Price — Recom None Prev Close $2.03
Price $1.96 Change -3.30%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.96
Latest analyst target
3. DCF / Fair value
$-45.71
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.96
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-03-06 reit HC Wainwright & Co. Buy → Buy $10
2024-01-30 init HC Wainwright & Co. — → Buy $10
News
RSS: Latest ENVB news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-23 PASQUALONE FRANK Director — 7,633 $0.00 $0
2025-12-23 SCHABACKER MARCUS Director — 7,633 $0.00 $0
2025-12-23 KEGLER GEORGE A. JR Director — 7,633 $0.00 $0
2025-12-23 TUCKER JOSEPH EDWARD Chief Executive Officer — 60,296 $0.00 $0
2025-12-23 COVENEY KEVIN MICHAEL Chief Financial Officer — 40,198 $0.00 $0
2025-12-23 DEWITT SHEILA Director — 7,633 $0.00 $0
2025-12-23 WEBB MICHAEL D Director — 7,633 $0.00 $0
2025-05-08 TUCKER JOSEPH EDWARD Chief Executive Officer — 98,866 — —
2025-05-08 FACCHINI PETER JAMES Chief Technology Officer — 24,717 — —
2025-05-08 COVENEY KEVIN MICHAEL Chief Financial Officer — 74,150 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Gross Profit
—
—
—
—
Operating Expense
8.77
-8.91%
9.63
-47.36%
18.30
-8.34%
19.96
Research And Development
2.78
-2.12%
2.84
-60.82%
7.25
-9.66%
8.03
Selling General And Administration
5.79
-10.24%
6.45
-39.69%
10.70
-7.80%
11.61
General And Administrative Expense
5.79
-10.24%
6.45
-39.69%
10.70
-7.80%
11.61
Other Gand A
5.79
-10.24%
6.45
-27.10%
8.85
-23.73%
11.61
Total Expenses
8.77
-8.91%
9.63
-47.36%
18.30
-8.34%
19.96
Operating Income
-8.77
+8.91%
-9.63
+47.36%
-18.30
+8.34%
-19.96
Total Operating Income As Reported
-8.77
+8.91%
-9.63
+41.44%
-16.45
+40.00%
-27.42
EBITDA
-8.57
+7.76%
-9.29
+48.04%
-17.89
+8.34%
-19.52
Normalized EBITDA
-8.57
+7.76%
-9.29
+50.87%
-18.92
+3.11%
-19.53
Reconciled Depreciation
0.20
-40.48%
0.34
-17.29%
0.41
-6.24%
0.44
EBIT
-8.77
+8.91%
-9.63
+47.36%
-18.30
+8.30%
-19.95
Total Unusual Items
—
0.05
-95.54%
1.03
+10976.86%
0.01
Total Unusual Items Excluding Goodwill
—
0.05
-95.54%
1.03
+10976.86%
0.01
Special Income Charges
—
—
0.00
+100.00%
-7.45
Impairment Of Capital Assets
—
—
0.00
-100.00%
7.45
Net Income
-8.77
+8.39%
-9.57
+44.69%
-17.31
+6.45%
-18.50
Pretax Income
-8.77
+8.30%
-9.57
+44.59%
-17.26
+13.50%
-19.96
Net Non Operating Interest Income Expense
-0.00
-148.40%
0.00
-94.09%
0.00
+170.64%
-0.01
Interest Expense Non Operating
—
—
—
0.01
Net Interest Income
-0.00
-148.40%
0.00
-94.09%
0.00
+170.64%
-0.01
Interest Expense
—
—
—
0.01
Interest Income Non Operating
—
0.00
-94.09%
0.00
—
Interest Income
—
0.00
-94.09%
0.00
—
Other Income Expense
0.00
-96.11%
0.07
-93.59%
1.03
+10976.86%
0.01
Other Non Operating Income Expenses
0.00
-96.11%
0.07
—
—
Gain On Sale Of Security
—
0.05
-95.54%
1.03
-86.20%
7.46
Tax Provision
0.00
-100.00%
0.01
-69.11%
0.03
+101.95%
-1.49
Tax Rate For Calcs
0.00
-100.00%
0.00
+0.00%
0.00
+182.02%
0.00
Tax Effect Of Unusual Items
0.00
0.00
-100.00%
0.22
+31139.45%
0.00
Net Income Including Noncontrolling Interests
-8.77
+8.39%
-9.57
+44.63%
-17.29
+6.39%
-18.47
Net Income From Continuing Operation Net Minority Interest
-8.77
+8.39%
-9.57
+44.69%
-17.31
+6.45%
-18.50
Net Income From Continuing And Discontinued Operation
-8.77
+8.39%
-9.57
+44.69%
-17.31
+6.45%
-18.50
Net Income Continuous Operations
-8.77
+8.39%
-9.57
+44.63%
-17.29
+6.39%
-18.47
Minority Interests
—
0.00
+100.00%
-0.02
+42.32%
-0.03
Normalized Income
-8.77
+8.39%
-9.57
+47.17%
-18.12
+2.10%
-18.51
Net Income Common Stockholders
-12.13
-26.70%
-9.57
+45.16%
-17.46
+7.14%
-18.80
Otherunder Preferred Stock Dividend
3.36
0.00
—
—
Diluted EPS
-36.24
+84.14%
-228.48
+84.30%
-1,455.48
-646.40%
-195.00
Basic EPS
-36.24
+84.14%
-228.48
+84.30%
-1,455.48
-646.40%
-195.00
Basic Average Shares
0.33
-33.44%
0.50
+249.39%
0.14
+49.31%
0.10
Diluted Average Shares
0.33
-33.44%
0.50
+249.39%
0.14
+49.31%
0.10
Diluted NI Availto Com Stockholders
-12.13
-26.70%
-9.57
+45.16%
-17.46
+7.14%
-18.80
Depreciation Amortization Depletion Income Statement
0.20
-40.48%
0.34
-1.89%
0.34
+4.90%
0.33
Depreciation And Amortization In Income Statement
0.20
-40.48%
0.34
-1.89%
0.34
+4.90%
0.33
Preferred Stock Dividends
—
—
0.15
-50.00%
0.30
Rent And Landing Fees
—
0.00
-100.00%
1.85
0.00
Rent Expense Supplemental
—
0.00
-100.00%
1.85
0.00
Total Other Finance Cost
0.00
+148.40%
-0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
5.10
+65.32%
3.08
-28.31%
4.30
-78.01%
19.55
Current Assets
4.94
+80.53%
2.73
-23.65%
3.58
-80.57%
18.43
Cash Cash Equivalents And Short Term Investments
4.68
+108.72%
2.24
-2.05%
2.29
-87.09%
17.72
Cash And Cash Equivalents
4.68
+108.72%
2.24
-2.05%
2.29
-87.09%
17.72
Cash Financial
4.68
+108.72%
2.24
-2.05%
2.29
-87.09%
17.72
Receivables
—
0.00
-100.00%
0.22
0.00
Taxes Receivable
—
0.00
-100.00%
0.22
0.00
Prepaid Assets
0.22
-56.24%
0.49
-1.55%
0.50
-29.19%
0.71
Current Deferred Assets
0.04
0.00
-100.00%
0.57
0.00
Other Current Assets
—
—
—
0.71
Total Non Current Assets
0.16
-54.24%
0.35
-51.56%
0.72
-35.92%
1.12
Net PPE
0.16
-47.92%
0.31
-39.73%
0.51
-31.56%
0.74
Gross PPE
0.83
+4.98%
0.80
-8.08%
0.87
-5.98%
0.92
Accumulated Depreciation
-0.68
-38.04%
-0.49
-36.81%
-0.36
-100.09%
-0.18
Machinery Furniture Equipment
0.03
+5.03%
0.03
-8.13%
0.03
+12.90%
0.03
Other Properties
0.81
+4.98%
0.77
-8.08%
0.84
-6.51%
0.89
Goodwill And Other Intangible Assets
0.00
-100.00%
0.04
-80.00%
0.21
-44.45%
0.38
Goodwill
—
—
—
0.00
Other Intangible Assets
—
—
—
0.38
Total Liabilities Net Minority Interest
0.92
-38.35%
1.49
-36.43%
2.34
-41.35%
4.00
Current Liabilities
0.92
-38.35%
1.49
-36.43%
2.34
-41.35%
4.00
Payables And Accrued Expenses
0.92
-38.35%
1.49
-35.07%
2.29
+5.79%
2.17
Payables
0.77
-24.51%
1.02
-18.16%
1.24
+167.90%
0.46
Accounts Payable
0.58
+11.36%
0.52
-57.19%
1.22
+163.08%
0.46
Other Payable
—
0.02
—
—
Current Accrued Expenses
0.15
-68.01%
0.47
-55.00%
1.05
-38.25%
1.71
Total Tax Payable
0.09
-67.11%
0.26
+1069.91%
0.02
0.00
Current Debt And Capital Lease Obligation
—
—
—
0.06
Current Capital Lease Obligation
—
—
0.00
-100.00%
0.06
Other Current Liabilities
—
0.00
-93.71%
0.05
-97.22%
1.76
Total Non Current Liabilities Net Minority Interest
0.00
0.00
0.00
0.00
Long Term Debt And Capital Lease Obligation
—
—
—
0.00
Long Term Capital Lease Obligation
—
—
—
0.00
Non Current Deferred Liabilities
—
—
—
0.00
Non Current Deferred Taxes Liabilities
—
—
—
0.00
Preferred Securities Outside Stock Equity
0.00
0.00
0.00
0.00
Stockholders Equity
4.18
+162.28%
1.59
-18.58%
1.96
-86.67%
14.67
Common Stock Equity
4.18
+162.28%
1.59
-18.58%
1.96
-86.67%
14.67
Capital Stock
0.01
+1778.76%
0.00
-69.07%
0.00
-91.21%
0.02
Common Stock
0.01
+1778.76%
0.00
-69.07%
0.00
-91.21%
0.02
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
1.06
+56.57%
0.68
+271.26%
0.18
+31.81%
0.14
Ordinary Shares Number
1.06
+56.57%
0.68
+271.26%
0.18
+31.81%
0.14
Additional Paid In Capital
119.59
+10.47%
108.26
+7.36%
100.84
+6.83%
94.40
Retained Earnings
-114.85
-8.27%
-106.07
-9.92%
-96.50
-21.83%
-79.21
Gains Losses Not Affecting Retained Earnings
-0.58
+2.44%
-0.59
-4.35%
-0.57
-6.15%
-0.54
Minority Interest
—
0.00
0.00
-100.00%
0.89
Other Equity Adjustments
-0.58
+2.44%
-0.59
-4.35%
-0.57
-6.15%
-0.54
Total Equity Gross Minority Interest
4.18
+162.28%
1.59
-18.58%
1.96
-87.42%
15.56
Total Capitalization
4.18
+162.28%
1.59
-18.58%
1.96
-86.67%
14.67
Working Capital
4.02
+222.79%
1.24
+0.55%
1.24
-91.42%
14.44
Invested Capital
4.18
+162.28%
1.59
-18.58%
1.96
-86.67%
14.67
Total Debt
—
—
0.00
-100.00%
0.06
Capital Lease Obligations
—
—
0.00
-100.00%
0.06
Net Tangible Assets
4.18
+169.41%
1.55
-11.16%
1.75
-87.79%
14.29
Tangible Book Value
4.18
+169.41%
1.55
-11.16%
1.75
-87.79%
14.29
Derivative Product Liabilities
—
—
—
—
Dueto Related Parties Current
0.10
-57.12%
0.23
0.00
—
Other Equity Interest
—
—
-1.82
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.14
-5.38%
-7.73
+45.18%
-14.09
+17.80%
-17.15
Cash Flow From Continuing Operating Activities
-8.14
-5.38%
-7.73
+45.18%
-14.09
+17.80%
-17.15
Net Income From Continuing Operations
-8.77
+8.39%
-9.57
+44.63%
-17.29
+6.39%
-18.47
Depreciation Amortization Depletion
0.20
-40.48%
0.34
-17.29%
0.41
-6.24%
0.44
Depreciation
0.16
-5.96%
0.17
-29.48%
0.24
-10.20%
0.27
Amortization Cash Flow
0.04
-75.00%
0.17
0.00%
0.17
+0.00%
0.17
Depreciation And Amortization
0.20
-40.48%
0.34
-17.29%
0.41
-6.24%
0.44
Amortization Of Intangibles
0.04
-75.00%
0.17
0.00%
0.17
+0.00%
0.17
Other Non Cash Items
-0.10
-123.73%
0.42
-77.37%
1.85
—
Stock Based Compensation
0.83
-47.05%
1.56
-27.34%
2.15
-17.95%
2.62
Asset Impairment Charge
—
—
0.00
-100.00%
7.45
Deferred Tax
—
—
0.00
+100.00%
-1.50
Deferred Income Tax
—
—
0.00
+100.00%
-1.50
Operating Gains Losses
-0.00
+94.42%
-0.05
+95.55%
-1.03
+86.14%
-7.46
Gain Loss On Investment Securities
-0.00
+94.42%
-0.05
+95.54%
-1.03
+86.20%
-7.46
Gain Loss On Sale Of PPE
—
0.00
+100.00%
-0.00
0.00
Change In Working Capital
-0.30
+30.08%
-0.42
-142.20%
-0.17
+19.71%
-0.22
Change In Prepaid Assets
0.25
+40.58%
0.18
+2703.12%
-0.01
+98.17%
-0.37
Change In Payables And Accrued Expense
-0.55
+9.12%
-0.60
-479.44%
-0.10
-139.38%
0.26
Change In Payable
-0.55
+9.12%
-0.60
-479.44%
-0.10
—
Change In Account Payable
-0.41
+50.41%
-0.83
-703.70%
-0.10
—
Change In Other Working Capital
—
—
-0.06
+40.31%
-0.11
Change In Other Current Liabilities
—
—
—
-0.11
Investing Cash Flow
—
0.00
-100.00%
0.01
+102.00%
-0.58
Cash Flow From Continuing Investing Activities
—
0.00
-100.00%
0.01
+102.00%
-0.58
Net PPE Purchase And Sale
—
0.00
-100.00%
0.01
+102.00%
-0.58
Purchase Of PPE
—
0.00
+100.00%
-0.01
+99.11%
-0.58
Sale Of PPE
—
0.00
-100.00%
0.02
0.00
Capital Expenditure
—
—
-0.01
+99.11%
-0.58
Net Business Purchase And Sale
—
—
—
0.00
Net Intangibles Purchase And Sale
—
—
—
0.00
Purchase Of Intangibles
—
—
—
0.00
Financing Cash Flow
10.58
+37.86%
7.67
+671.33%
-1.34
-107.39%
18.18
Cash Flow From Continuing Financing Activities
10.58
+37.86%
7.67
+671.33%
-1.34
-107.39%
18.18
Net Issuance Payments Of Debt
—
—
—
—
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
—
—
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
5.88
+74.32%
3.37
0.00
-100.00%
17.22
Repurchase Of Capital Stock
—
0.00
+100.00%
-1.05
0.00
Proceeds From Stock Option Exercised
4.70
+4.83%
4.48
0.00
0.00
Net Other Financing Charges
—
-0.18
+37.52%
-0.29
-130.38%
0.96
Changes In Cash
2.44
+4761.05%
-0.05
+99.66%
-15.43
-3533.70%
0.45
Effect Of Exchange Rate Changes
-0.00
-128.00%
0.01
+153.42%
-0.01
+87.68%
-0.08
Beginning Cash Position
2.24
-2.05%
2.29
-87.09%
17.72
+2.12%
17.36
End Cash Position
4.68
+108.72%
2.24
-2.05%
2.29
-87.09%
17.72
Free Cash Flow
-8.14
-5.38%
-7.73
+45.20%
-14.10
+20.48%
-17.73
Interest Paid Supplemental Data
0.00
0.00
0.00
-100.00%
0.01
Income Tax Paid Supplemental Data
0.00
-100.00%
0.01
-47.41%
0.01
0.00
Common Stock Issuance
5.88
+74.32%
3.37
0.00
-100.00%
17.22
Issuance Of Capital Stock
5.88
+74.32%
3.37
0.00
-100.00%
17.22
Net Preferred Stock Issuance
—
0.00
+100.00%
-1.05
0.00
Preferred Stock Payments
—
0.00
+100.00%
-1.05
0.00
Sale Of Business
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category